Clinical application value of metagenomic second-generation sequencing technology in hematologic diseases with and without transplantation

INTRODUCTION: Hematological patients are at risk of infections. It is unknown whether the pathogenic microbial spectrum differs between HSCT and non-HSCT patients, and whether metagenomic next-generation sequencing (mNGS) of peripheral blood can be used as a substitute test specimen such as alveolar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xia, Wang, Fang, Yu, Jifeng, Jiang, Zhongxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311908/
https://www.ncbi.nlm.nih.gov/pubmed/37396304
http://dx.doi.org/10.3389/fcimb.2023.1135460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311908/
https://www.ncbi.nlm.nih.gov/pubmed/37396304
http://dx.doi.org/10.3389/fcimb.2023.1135460

Ejemplares similares